SeqOne
Created in 2017
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
73 150 6,447Activities
Technologies
Entity types
Location
22 Rue Durand, 34000 Montpellier, France
Montpellier
France
Employees
Scale: 51-200
Estimated: 84
Engaged corporates
14
6 8Added in Motherbase
5 years, 4 months ago
biotech Value proposition
From Genome to Personalized Medicine
Founded in 2017, SeqOne Genomics headquartered in Montpellier, France, is a fast-growing deep-tech company focused on turning genomic data into medically actionable insights in oncology, rare and inherited diseases. SeqOne clinical genomic analysis platform, powered by explainable AI, provides genomic labs and healthcare professionals with best-in-class accuracy, usability, and automation seamlessly across lab technologies. By streamlining complex multi-omics analysis workflows, we pave the way for a new era of personalized healthcare at scale, where genetic testing becomes as routine as traditional blood work, radically enhancing health outcomes for all. The company has won numerous awards, including the iLab award and the ARC Cancer Foundation’s Hélène Stark prize. It has been nominated twice for the prestigious Prix Galien award. Investors include Elaia, IRDI Capital Investissement, Merieux Equity Partners, Omnes, and Software Club.
Precision Medicine, Genetics, Genomics, NGS, Bioinformatics, Transcriptomics, Epigenomics, Companion Diagnostics, IVD, and CE IVDROriginal language
From Genome to Personalized Medicine
Founded in 2017, SeqOne Genomics headquartered in Montpellier, France, is a fast-growing deep-tech company focused on turning genomic data into medically actionable insights in oncology, rare and inherited diseases.
SeqOne clinical genomic analysis platform, powered by explainable AI, provides genomic labs and healthcare professionals with best-in-class accuracy, usability, and automation seamlessly across lab technologies.
By streamlining complex multi-omics analysis workflows, we pave the way for a new era of personalized healthcare at scale, where genetic testing becomes as routine as traditional blood work, radically enhancing health outcomes for all.
The company has won numerous awards, including the iLab award and the ARC Cancer Foundation’s Hélène Stark prize. It has been nominated twice for the prestigious Prix Galien award. Investors include Elaia, IRDI Capital Investissement, Merieux Equity Partners, Omnes, and Software Club.
Home - SeqOne
The most advanced platform for clinical genomic analysis: don't miss a mutation, increase your team’s productivity, meet quality and compliance goals, keep your data safe and accessible
https://seqone.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Regeneron Pharmaceutical, Biotechnology, Biotechnology Research | Regeneron Pharmaceutical, Biotechnology, Biotechnology Research | Other 9 Oct 2024 | | |
 Alexion Pharmaceuticals, Inc. Pharmaceutical, Biotechnology, Biotechnology Research | Alexion Pharmaceuticals, Inc. Pharmaceutical, Biotechnology, Biotechnology Research | Other 9 Oct 2024 | | |
 Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Other 17 Jun 2024 | | |
 Orange Telecoms, Law Practice, Telecommunications | Orange Telecoms, Law Practice, Telecommunications | Not capitalistic Not partnership Event 26 Jun 2019 | | |
 | SATT AxLR | Other 5 Jul 2022 | | |
 La Région Occitanie / Pyrénées-Méditerranée National and local authorities, Government Administration | La Région Occitanie / Pyrénées-Méditerranée National and local authorities, Government Administration | Other 8 Aug 2023 | | |
 CNRS Research, Research Services | CNRS Research, Research Services | Other 21 Oct 2022 | | |
 Omnes Startup accelerator & VC, Financial Services | Omnes Startup accelerator & VC, Financial Services | Other 30 Jan 2024 | | |
 Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Other 9 Feb 2022 | | |
 AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 9 Oct 2024 | | |